Balchem Corp (BCPC) 58.18 $BCPC
Shares of BCPC Down 9.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 12, 4:53PM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.22. In approximately 1 month, Balchem has returned 9.31% as of today's recent price of $57.34.
BCPC: 58.18 (+0.84)
13.2% Return Seen to Date on SmarTrend Balchem Call (BCPC)
Comtex SmarTrend(R) - Thu Feb 05, 11:15AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 1 month, Balchem has returned 13.17% as of today's recent price of $54.90.
BCPC: 58.18 (+0.84)
Shares of BCPC Down 16.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 29, 10:00AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 3 weeks, Balchem has returned 16.09% as of today's recent price of $53.05.
BCPC: 58.18 (+0.84)
Downtrend Call Working As Balchem Stock Falls 19.6% (BCPC)
Comtex SmarTrend(R) - Thu Jan 22, 10:05AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 2 weeks, Balchem has returned 19.64% as of today's recent price of $50.81.
BCPC: 58.18 (+0.84)
Balchem slides after new short report
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 1:06PM CST
BCPC: 58.18 (+0.84)
Uptrend Call Working As Balchem Stock Rises 17.2% (BCPC)
Comtex SmarTrend(R) - Fri Jan 02, 9:30AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 3 months, Balchem has returned 17.24% as of today's recent price of $66.85.
BCPC: 58.18 (+0.84)
Balchem: Staying Bullish As The Company Hikes Its Dividend
Heather Ingrassia - at Seeking Alpha - Wed Dec 31, 10:50AM CST
BCPC: 58.18 (+0.84)
Balchem declares $0.30 dividend
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 2:06PM CST
BCPC: 58.18 (+0.84)
Balchem Corporation Announces Dividend
GlobeNewswire - Fri Dec 19, 2:00PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.30 per share, payable on January 27, 2015 to holders of record on December 29, 2014. This dividend reflects a 15% increase over the prior year cash dividend.
BCPC: 58.18 (+0.84)
Balchem Has Returned 13.7% Since SmarTrend Recommendation (BCPC)
Comtex SmarTrend(R) - Wed Dec 17, 11:15AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 months, Balchem has returned 13.68% as of today's recent price of $64.82.
BCPC: 58.18 (+0.84)
Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 47.28 (-0.25), BA: 149.73 (+1.64), BCPC: 58.18 (+0.84), MMS: 59.14 (+0.12)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.00 (+0.27), MJN: 101.89 (+2.32), CBM: 32.96 (+0.09), SIAL: 138.20 (+0.07), USNA: 101.37 (+0.53), SYUT: 5.29 (unch), MTEX: 23.89 (+0.69), BCPC: 58.18 (+0.84)
Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST
HOG: 63.90 (+0.82), LAZ: 50.90 (+0.18), AIV: 38.55 (-0.50), CNP: 21.76 (-0.35), AIT: 42.60 (+0.09), UPS: 101.79 (+0.38), SLB: 88.38 (+2.42), PRI: 55.09 (+0.55), VLO: 58.60 (+2.05), MAT: 27.61 (+0.17), AJG: 47.50 (+0.27), MMLP: 30.17 (+0.19), HME: 67.76 (-0.96), MWE: 60.94 (+1.13), RES: 13.36 (+0.93), INGR: 82.82 (+0.59), PFE: 34.64 (-0.23), ALL: 71.46 (-0.11), CLB: 112.18 (+3.65), RAS: 7.38 (+0.06), MCO: 98.22 (+0.01), FLIR: 33.01 (-0.23), SMP: 39.33 (-0.14), CPA: 119.12 (+0.27), ARCP: 9.40 (+0.06), HEI: 62.50 (+0.89), EWBC: 40.60 (+0.37), MKTX: 81.22 (-0.66), SNI: 73.00 (+0.39), BCPC: 58.18 (+0.84), FCF: 8.62 (-0.10), GMT: 60.08 (-0.44), ALE: 53.65 (-1.17), TAL: 41.00 (+0.37), EMCF: 24.03 (-0.87), WDR: 49.94 (+0.15), TLLP: 55.75 (-0.07), EPR: 61.68 (-0.30), EME: 43.70 (+0.61), PCBK: 13.44 (-0.04), X: 26.36 (+1.12), CMS: 34.65 (-0.88), LGCY: 13.35 (+0.51), CUBE: 24.28 (-0.32), AMGN: 153.48 (+0.30), EFX: 92.56 (-0.18), ATK: 140.03 (+0.78), FINL: 23.51 (-0.32), LEA: 108.70 (-0.73), TESS: 25.19 (+0.29), LB: 94.51 (-0.30), HPY: 49.42 (-5.71), DNB: 133.27 (+0.46), BIP: 46.20 (-0.21), TOO: 20.51 (+0.25), FIBK: 26.15 (+0.06), CNA: 43.40 (+0.18), MOFG: 28.75 (-0.48)
Balchem Announces Investment in Agglomeration Technology
GlobeNewswire - Tue Nov 25, 3:39PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its SensoryEffects business segment will make a multi-million dollar investment in agglomeration technology and production equipment to complement its market leading capabilities in drying and blending of emulsified powders for various markets.
BCPC: 58.18 (+0.84)
Post Earnings Update: Balchem Has Sunk 3.2% Lower in Past 2 Weeks (BCPC)
Comtex SmarTrend(R) - Mon Nov 24, 8:42AM CST
14 days ago, on November 10th, 2014, Balchem (NASDAQ:BCPC) reported its earnings. Analysts, on average, expected earnings of $0.51 per share on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Since the company's report, shares of Balchem have fallen from $65.73 to $63.61, representing a loss of 3.2% in the past 14 days.
BCPC: 58.18 (+0.84)
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Balchem Is Down 1.4% (BCPC)
Comtex SmarTrend(R) - Mon Nov 17, 2:55PM CST
A week ago on November 10th, 2014 Balchem (NASDAQ:BCPC) reported earnings and analysts, on average, expected earnings of $0.51 on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Shares of Balchem have slipped from $65.73 to $64.84, representing a loss of 1.4%, since the company reported earnings 7 days ago.
BCPC: 58.18 (+0.84)
Shares of BCPC Down 9.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 12, 4:53PM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.22. In approximately 1 month, Balchem has returned 9.31% as of today's recent price of $57.34.
BCPC: 58.18 (+0.84)
13.2% Return Seen to Date on SmarTrend Balchem Call (BCPC)
Comtex SmarTrend(R) - Thu Feb 05, 11:15AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 1 month, Balchem has returned 13.17% as of today's recent price of $54.90.
BCPC: 58.18 (+0.84)
Shares of BCPC Down 16.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 29, 10:00AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 3 weeks, Balchem has returned 16.09% as of today's recent price of $53.05.
BCPC: 58.18 (+0.84)
Downtrend Call Working As Balchem Stock Falls 19.6% (BCPC)
Comtex SmarTrend(R) - Thu Jan 22, 10:05AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 2 weeks, Balchem has returned 19.64% as of today's recent price of $50.81.
BCPC: 58.18 (+0.84)
Balchem slides after new short report
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 1:06PM CST
BCPC: 58.18 (+0.84)
Uptrend Call Working As Balchem Stock Rises 17.2% (BCPC)
Comtex SmarTrend(R) - Fri Jan 02, 9:30AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 3 months, Balchem has returned 17.24% as of today's recent price of $66.85.
BCPC: 58.18 (+0.84)
Balchem: Staying Bullish As The Company Hikes Its Dividend
Heather Ingrassia - at Seeking Alpha - Wed Dec 31, 10:50AM CST
BCPC: 58.18 (+0.84)
Balchem declares $0.30 dividend
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 2:06PM CST
BCPC: 58.18 (+0.84)
Balchem Corporation Announces Dividend
GlobeNewswire - Fri Dec 19, 2:00PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.30 per share, payable on January 27, 2015 to holders of record on December 29, 2014. This dividend reflects a 15% increase over the prior year cash dividend.
BCPC: 58.18 (+0.84)
Balchem Has Returned 13.7% Since SmarTrend Recommendation (BCPC)
Comtex SmarTrend(R) - Wed Dec 17, 11:15AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 months, Balchem has returned 13.68% as of today's recent price of $64.82.
BCPC: 58.18 (+0.84)
Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 47.28 (-0.25), BA: 149.73 (+1.64), BCPC: 58.18 (+0.84), MMS: 59.14 (+0.12)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.00 (+0.27), MJN: 101.89 (+2.32), CBM: 32.96 (+0.09), SIAL: 138.20 (+0.07), USNA: 101.37 (+0.53), SYUT: 5.29 (unch), MTEX: 23.89 (+0.69), BCPC: 58.18 (+0.84)
Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST
HOG: 63.90 (+0.82), LAZ: 50.90 (+0.18), AIV: 38.55 (-0.50), CNP: 21.76 (-0.35), AIT: 42.60 (+0.09), UPS: 101.79 (+0.38), SLB: 88.38 (+2.42), PRI: 55.09 (+0.55), VLO: 58.60 (+2.05), MAT: 27.61 (+0.17), AJG: 47.50 (+0.27), MMLP: 30.17 (+0.19), HME: 67.76 (-0.96), MWE: 60.94 (+1.13), RES: 13.36 (+0.93), INGR: 82.82 (+0.59), PFE: 34.64 (-0.23), ALL: 71.46 (-0.11), CLB: 112.18 (+3.65), RAS: 7.38 (+0.06), MCO: 98.22 (+0.01), FLIR: 33.01 (-0.23), SMP: 39.33 (-0.14), CPA: 119.12 (+0.27), ARCP: 9.40 (+0.06), HEI: 62.50 (+0.89), EWBC: 40.60 (+0.37), MKTX: 81.22 (-0.66), SNI: 73.00 (+0.39), BCPC: 58.18 (+0.84), FCF: 8.62 (-0.10), GMT: 60.08 (-0.44), ALE: 53.65 (-1.17), TAL: 41.00 (+0.37), EMCF: 24.03 (-0.87), WDR: 49.94 (+0.15), TLLP: 55.75 (-0.07), EPR: 61.68 (-0.30), EME: 43.70 (+0.61), PCBK: 13.44 (-0.04), X: 26.36 (+1.12), CMS: 34.65 (-0.88), LGCY: 13.35 (+0.51), CUBE: 24.28 (-0.32), AMGN: 153.48 (+0.30), EFX: 92.56 (-0.18), ATK: 140.03 (+0.78), FINL: 23.51 (-0.32), LEA: 108.70 (-0.73), TESS: 25.19 (+0.29), LB: 94.51 (-0.30), HPY: 49.42 (-5.71), DNB: 133.27 (+0.46), BIP: 46.20 (-0.21), TOO: 20.51 (+0.25), FIBK: 26.15 (+0.06), CNA: 43.40 (+0.18), MOFG: 28.75 (-0.48)
Balchem Announces Investment in Agglomeration Technology
GlobeNewswire - Tue Nov 25, 3:39PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its SensoryEffects business segment will make a multi-million dollar investment in agglomeration technology and production equipment to complement its market leading capabilities in drying and blending of emulsified powders for various markets.
BCPC: 58.18 (+0.84)
Post Earnings Update: Balchem Has Sunk 3.2% Lower in Past 2 Weeks (BCPC)
Comtex SmarTrend(R) - Mon Nov 24, 8:42AM CST
14 days ago, on November 10th, 2014, Balchem (NASDAQ:BCPC) reported its earnings. Analysts, on average, expected earnings of $0.51 per share on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Since the company's report, shares of Balchem have fallen from $65.73 to $63.61, representing a loss of 3.2% in the past 14 days.
BCPC: 58.18 (+0.84)
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Balchem Is Down 1.4% (BCPC)
Comtex SmarTrend(R) - Mon Nov 17, 2:55PM CST
A week ago on November 10th, 2014 Balchem (NASDAQ:BCPC) reported earnings and analysts, on average, expected earnings of $0.51 on sales of $157.0 million. Balchem actually reported earnings of $0.65 per share on sales of $160.5 million, beating EPS estimates by $0.15 and beating revenue estimates by $3.5 million. Shares of Balchem have slipped from $65.73 to $64.84, representing a loss of 1.4%, since the company reported earnings 7 days ago.
BCPC: 58.18 (+0.84)
